Evidence map

ReviewCancer cell international2026

Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer.

Pouya Goleij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42210223